Pharmaceutical-embodied technical progress, longevity and quality of life: drugs as 'equipment for your health.'
Article Abstract:
The impacts of technical progress in pharmaceutical industry, in terms of new drugs, on quality of life and improving health conditions are investigated. Findings show that people who consumed newer medicines experienced better health conditions after treatment and had fewer limitations than those who consulmed older drugs. The role of techn ical progress in drugs, as compared to that in equipment, in increasing economic equality and growth is analyzed.
Publication Name: Managerial & Decision Economics
Subject: Economics
ISSN: 0143-6570
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Commentary
Article Abstract:
A paper on regulation, competition and differentiation of various statins is reviewed. Economists were fount to be more concerned about generic competition instead of therapeutic competition. Recommendations for future research are supplied.
Publication Name: Managerial & Decision Economics
Subject: Economics
ISSN: 0143-6570
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Aggregate returns to scale embodied technology change: theory and measurement using stock market data
- Abstracts: The most technologically progressive decade of the century. Inequality, lobbying, and resource allocation. Mortality reductions, educational attainment, and fertility choice
- Abstracts: Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion. Benefits and costs of newer drugs: an update
- Abstracts: The cost of biopharmaceutical R&D: is biotech different? Commentary. Generic competition and market exclusivity periods
- Abstracts: Commentary. Commentary: drug and vaccine pricing and innovation, what is the story?